NCT00117234View on ClinicalTrials.gov

Impact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and Anemia

NACompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2002

Study Completion Date

July 31, 2004

Conditions
Congestive Heart FailureAnemia
Interventions
DRUG

darbepoetin alfa

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY